Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
828 participants
OBSERVATIONAL
2025-09-01
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico)
NCT06345352
COVID-19 Impact on the Lombardy Region's Emergency System
NCT04669925
Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Hospitalizations
NCT06846879
Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (ASST Papa Giovanni XXIII)
NCT06345378
Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department
NCT01444768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Fenice has proposed a new indicator to measure the level of crowding in EDs. The indicator was developed to measure one of the objective consequences of crowding in EDs, namely the increase in waiting time for patients with a problem classified as minor urgency or deferrable to triage (codes 3 and 4). In parallel, the Fenice study has shown that NEDOCS is not very sensitive to this objective consequence of crowding.
The aim of this study is to evaluate, in a national multicenter context, the degree of agreement between the Fenice indicator and the perception of crowding of the operators of the ER and to compare this agreement with that between NEDOCS and the perception of the operators.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elegible population
All patients arrived in ED during the year 2024 and patientes arrived in the period of active monitoring of the perception of crowding.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mario Negri Institute for Pharmacological Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giovanni Nattino
Role: STUDY_CHAIR
Istituto di Ricerche Farmacologiche Mario Negri IRCSS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spedali civili
Brescia, BS, Italy
IRCCS San Martino
Genova, GE, Italy
Ospedale Santa Maria delle Croci
Ravenna, RA, Italy
Ospedali riuniti di Anzio e Nettuno
Anzio, RM, Italy
Azienda Ospedaliera San Camillo Forlanini
Roma, RM, Italy
Presidio Osped. Riunito
Cirié, TO, Italy
AOU San Luigi Gonzaga
Orbassano, TO, Italy
P.O. Sant'Andrea
Vercelli, VC, Italy
AOU Maggiore della CaritÃ
Novara, , Italy
Ospedale Santa Maria delle Grazie
Pozzuoli, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAOS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.